EFFECTS OF RAMIPRIL, TELMISARTAN AND THEIR COMBINATION ON AMBULATORY BLOOD PRESSURE IN AN ONTARGET SUBSTUDY

被引：0
作者：
Mancia, G. [1 ]
Parati, G. [1 ]
Bilo, G. [1 ]
Giglio, A. [1 ]
Gao, P. [2 ]
Verdecchia, P. [3 ]
Redon, J. [4 ]
Sleight, P. [5 ]
Fagard, R. H. [6 ]
Yusuf, S. [2 ]
Teo, K. [2 ]
机构：
[1] Univ Milano Bicocca, Ist Auxol Italiano, Milan, Italy
[2] McMaster Univ, Hamilton, ON, Canada
[3] Hosp S Maria della Misericordia, Perugia, Italy
[4] Univ Valencia, Valencia, Spain
[5] John Radcliffe Hosp, Oxford OX3 9DU, England
[6] Univ Louvain, Leuven, Belgium
来源：
JOURNAL OF HYPERTENSION | 2009年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [21] The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I)
    Williams, B
    Gosse, P
    Lowe, L
    Harper, R
    JOURNAL OF HYPERTENSION, 2006, 24 (01) : 193 - 200
  • [22] Effects of ramipril/amlodipine combination versus amlodipine monotherapy on ambulatory blood pressure and laboratory tests. ATAR study
    Miranda, R. D.
    Mion, D., Jr.
    Rocha, J. C.
    Kohlmann, O., Jr.
    Luna-Filho, B.
    Gomes, M. A.
    Saraiva, J. F.
    Amodeo, C.
    JOURNAL OF HYPERTENSION, 2007, 25 : S377 - S377
  • [23] Telmisartan is as affective as ramipril in preventing cardiovascular events in high-risk patients, but no additional protective benefit was achieved if ramipril and telmisartan are combined - ONTARGET trial
    不详
    DIABETES OBESITY & METABOLISM, 2008, 10 (07) : 604 - 605
  • [24] Evaluation of hypotensive effect of telmisartan and telmisartan with hydrochlorothiazide in ambulatory blood pressure monitoring
    Uruski, Pawel
    Kostka-Jeziorny, Katarzyna
    Szczech, Radoslaw
    Tykarski, Andrzej
    ARTERIAL HYPERTENSION, 2010, 14 (01): : 74 - 82
  • [25] Safety and Efficacy of Low Blood Pressures Among Patients With Diabetes Subgroup Analyses From the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)
    Redon, Josep
    Mancia, Giuseppe
    Sleight, Peter
    Schumacher, Helmut
    Gao, Peggy
    Pogue, Janice
    Fagard, Robert
    Verdecchia, Paolo
    Weber, Michael
    Boehm, Michael
    Williams, Bryan
    Yusoff, Khalid
    Teo, Koon
    Yusuf, Salim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (01) : 74 - 83
  • [26] Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation
    Fogari, R
    Preti, P
    Zoppi, A
    Corradi, L
    Pasotti, C
    Rinaldi, A
    Mugellini, A
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 577 - 583
  • [27] Telmisartan, Ramipril, or both in patients at high risk for vascular events. Results of the ONTARGET trial
    Lyakishev, A. A.
    KARDIOLOGIYA, 2008, 48 (05) : 72 - 72
  • [28] Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension
    M. Soergel
    M. Verho
    E. Wühl
    J. Gellermann
    L. Teichert
    K. Schärer
    Pediatric Nephrology, 2000, 15 : 113 - 118
  • [29] Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension
    Soergel, M
    Verho, M
    Wühl, E
    Gellermann, J
    Teichert, L
    Schärer, K
    PEDIATRIC NEPHROLOGY, 2000, 15 (1-2) : 113 - 118
  • [30] Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data
    Yu Li-tian
    Zhu Jun
    Tan Hui-qiong
    Wang Guo-gan
    Teo, Koon K.
    Liu Li-sheng
    CHINESE MEDICAL JOURNAL, 2011, 124 (12) : 1763 - 1768
12345